FLT3 and acute myeloid leukemia: FLT3 mutations occur in approximately 30% of AML patients [17]; the most frequent alterations are internal tandem duplications (ITD) in the juxtamembrane domain and point mutations of the D835 hotspot in the tyrosine kinase domain (TKD).